Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 29 April 2009, doi:10.1136/bmj.b1730
Cite this as: BMJ 2009;338:b1730
| The first 100% of the full text of this article appears below. |
The conclusions of Moore and colleagues about nicotine replacement therapy seem to be slanted.1 With a long term smoking cessation percentage of only 1.6%, you can hardly call nicotine replacement an "effective" intervention. Although the 1.6% abstinence rate is better than the 0.4% achieved with placebo, how can one call the 1.6% success rate with nicotine replacement "effective"?
The logical conclusion from this systematic review and meta-analysis is that nicotine replacement was a dismal intervention. Most smokers (98.4%) failed to achieve long term sustained abstinence with it.
I cannot think of another intervention for which a 98.4% failure rate would be considered a success.
Cite this as: BMJ 2009;338:b1730
Michael Siegel, professor1
1 Boston University School of Public Health, Boston, MA 02118, USA
mbsiegel@bu.edu